U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C8H12O4
Molecular Weight 172.1785
Optical Activity NONE
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 1,4-CYCLOHEXANEDICARBOXYLIC ACID, TRANS-

SMILES

OC(=O)[C@H]1CC[C@@H](CC1)C(O)=O

InChI

InChIKey=PXGZQGDTEZPERC-IZLXSQMJSA-N
InChI=1S/C8H12O4/c9-7(10)5-1-2-6(4-3-5)8(11)12/h5-6H,1-4H2,(H,9,10)(H,11,12)/t5-,6-

HIDE SMILES / InChI

Molecular Formula C8H12O4
Molecular Weight 172.1785
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

PubMed

PubMed

TitleDatePubMed
Degradation and drug delivery properties of poly(1,4-cyclohexanedicarboxylic anhydride).
2001
The simplest supramolecular complexes containing pairs of Mo(2)(formamidinate)(3) units linked with various dicarboxylates: preparative methods, structures, and electrochemistry.
2001 Mar 12
Isomer separation, conformation control of flexible cyclohexanedicarboxylate ligand in cadmium complexes.
2004 Sep 21
Lamellar and three-dimensional hybrid compounds formed by cyclohexene- and cyclohexanedicarboxylates of Pb, La, and Cd.
2007
Metal-organic frameworks from copper dimers with cis- and trans-1,4-cyclohexanedicarboxylate and cis,cis-1,3,5-cyclohexanetricarboxylate.
2007 Jul 23
Poly[di-μ-cis-cyclo-hexane-1,4-dicarboxyl-ato-μ-trans-cyclo-hexane-1,4-dicarboxyl-ato-bis-[dipyrido[3,2-a:2',3'-c]phenazine]trimanganese(II)].
2008 May 7
Poly[tetra-kis(μ-cyclo-hexa-ne-1,4-di-carboxyl-ato)di-μ-hydroxido-penta-zinc(II)].
2009 Dec 4
Poly[[[μ-1,1'-(butane-1,4-di-yl)diimidazole-κN:N](μ-cyclo-hexane-1,4-dicarboxyl-ato-κO,O:O,O)nickel(II)] 0.25-hydrate].
2009 Feb 11
catena-Poly[[bis-(4-carboxy-cyclo-hexane-carboxyl-ato-κO,O)cadmium(II)]-μ-1,4-bis-(imidazol-1-ylmeth-yl)benzene-κN:N].
2009 Jun 10
Poly[[μ(2)-1,4-bis-(imidazol-1-ylmeth-yl)benzene]bis-(μ(4)-cyclo-hexane-1,4-dicarboxyl-ato)dicobalt(II)].
2009 Sep 5
Poly[[μ(2)-1,2-bis-(imidazol-1-ylmeth-yl)benzene](μ(2)-cyclo-hexane-1,4-dicarboxyl-ato)cobalt(II)].
2010 Feb 24
The N domain of human angiotensin-I-converting enzyme: the role of N-glycosylation and the crystal structure in complex with an N domain-specific phosphinic inhibitor, RXP407.
2010 Nov 12
Patents
Substance Class Chemical
Created
by admin
on Fri Dec 15 17:56:31 UTC 2023
Edited
by admin
on Fri Dec 15 17:56:31 UTC 2023
Record UNII
18W55738KH
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
1,4-CYCLOHEXANEDICARBOXYLIC ACID, TRANS-
Common Name English
TRANS-1,4-CYCLOHEXANEDICARBOXYLIC ACID
Systematic Name English
TRANS-HEXAHYDROTEREPHTHALIC ACID
Systematic Name English
TRANS-1,4-CYCLOHEXANE-1,4-DICARBOXYLIC ACID
Common Name English
NSC-621
Code English
Code System Code Type Description
EPA CompTox
DTXSID901031536
Created by admin on Fri Dec 15 17:56:31 UTC 2023 , Edited by admin on Fri Dec 15 17:56:31 UTC 2023
PRIMARY
FDA UNII
18W55738KH
Created by admin on Fri Dec 15 17:56:31 UTC 2023 , Edited by admin on Fri Dec 15 17:56:31 UTC 2023
PRIMARY
CAS
619-82-9
Created by admin on Fri Dec 15 17:56:31 UTC 2023 , Edited by admin on Fri Dec 15 17:56:31 UTC 2023
PRIMARY
ECHA (EC/EINECS)
210-614-2
Created by admin on Fri Dec 15 17:56:31 UTC 2023 , Edited by admin on Fri Dec 15 17:56:31 UTC 2023
PRIMARY
NSC
621
Created by admin on Fri Dec 15 17:56:31 UTC 2023 , Edited by admin on Fri Dec 15 17:56:31 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> METABOLITE
One percent percent of an oral dose are excreted as a dicarboxylic acid